AstraZeneca PLC (LON:AZN)
10,176
-4 (-0.04%)
May 14, 2025, 8:14 AM BST
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
451.28K GBP
Profits / Employee
63.79K GBP
Market Cap
157.85B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Oxford Nanopore Technologies | 1,382 |
AstraZeneca News
- 20 hours ago - AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025 - Business Wire
- 1 day ago - AstraZeneca and GSK in the firing line as Trump targets big pharma: ALEX BRUMMER - This is Money
- 1 day ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 1 day ago - Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%' - The Guardian
- 2 days ago - AstraZeneca (AZN) Faces Market Uncertainty Amid Drug Pricing Changes | AZN Stock News - GuruFocus
- 4 days ago - AstraZeneca's bladder cancer treatment shows positive results in trial - Seeking Alpha
- 4 days ago - IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial - Business Wire
- 6 days ago - AstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancer - Seeking Alpha